Ross Dickins, PhD, an associate professor at Monash University in Australia, is one of 91 researchers to receive a grant through The Marks Foundation’s ASPIRE (Accelerating Scientific Platforms and Innovative Research) program. Grants are awarded to high-risk, high-reward projects that aim to answer key feasibility and proof-of-concept questions in an accelerated timeframe. The 2021 grantees represent top academic institutions in seven countries, including Australia, France, Netherlands, Spain, Sweden, the United Kingdom, and the United States of America.

Dr. Dickins’ research project Preventing Relapse Following Acute Myeloid Leukemia Differentiation Therapy was awarded $232K from the Marks Foundation. The project will investigate new strategies to prevent relapse in acute myeloid leukemia patients.

The Leukemia Research Foundation supported Dr. Dickins’ research in 2003-2004.